Isolated heart model demonstrates evidence of contractile and diastolic dysfunction in right ventricles from rats with sugen/hypoxia-induced pulmonary hypertension

Physiological Reports

Volumn 5, Issue 19, 2017, Pages

  Neto Neves, Evandro M ^a,c   Frump, Andrea L ^a   Vayl, Alexandra ^a   Kline, Jeffrey A ^a   Lahm, Tim ^a,b  

^a INDIANA UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b RICHARD L ROUDEBUSH VETERANS AFFAIRS MEDICAL CENTER   (United States)

^c UNIVERSITY OF SÃO PAULO   (Brazil)

Author keywords

apelin; apoptosis; bcl 2 bax; Langendorff; p38MAPK; right ventricular hypertrophy

Indexed keywords

APELIN; BAX PROTEIN, RAT; BCL2 PROTEIN, RAT; INDOLE DERIVATIVE; MITOGEN ACTIVATED PROTEIN KINASE P38; PROTEIN BAX; PROTEIN BCL 2; PYRROLE DERIVATIVE; SEMAXANIB;

ANIMAL; CARDIAC MUSCLE; COMPLICATION; DIASTOLE; GENETICS; HEART; HEART CONTRACTION; HEART RIGHT VENTRICLE FUNCTION; HYPOXIA; ISOLATED HEART; MALE; METABOLISM; PATHOPHYSIOLOGY; PULMONARY HYPERTENSION; RAT; SPRAGUE DAWLEY RAT;

ANIMALS; APELIN; BCL-2-ASSOCIATED X PROTEIN; DIASTOLE; HEART; HYPERTENSION, PULMONARY; HYPOXIA; INDOLES; ISOLATED HEART PREPARATION; MALE; MYOCARDIAL CONTRACTION; MYOCARDIUM; P38 MITOGEN-ACTIVATED PROTEIN KINASES; PROTO-ONCOGENE PROTEINS C-BCL-2; PYRROLES; RATS; RATS, SPRAGUE-DAWLEY; VENTRICULAR DYSFUNCTION, RIGHT;

EID: 85047752808     PISSN: None     EISSN: 2051817X     Source Type: Journal    
DOI: 10.14814/phy2.13438     Document Type: Article

References (60)

1. Alastalo, T. P., M. Li, J. Perez Vde, D. Pham, H. Sawada, J. K. Wang, et al. 2011. Disruption of PPARgamma/beta-catenin-mediated regulation of apelin impairs BMP-induced mouse and human pulmonary arterial EC survival. J. Clin. Invest. 121:3735–3746.
2. Andersen, C. U., O. Hilberg, S. Mellemkjaer, J. E. Nielsen-Kudsk, and U. Simonsen. 2011. Apelin and pulmonary hypertension. Pulm. Circ. 1:334–346.
3. Andersen, S., J. G. Schultz, A. Andersen, S. Ringgaard, J. M. Nielsen, S. Holmboe, et al. 2014. Effects of bisoprolol and losartan treatment in the hypertrophic and failing right heart. J. Card. Fail. 20:864–873.
4. Azizi, Y., M. Faghihi, A. Imani, M. Roghani, A. Zekri, M. B. Mobasheri, et al. 2015. Post-infarct treatment with [Pyr(1)]apelin-13 improves myocardial function by increasing neovascularization and overexpression of angiogenic growth factors in rats. Eur. J. Pharmacol. 761:101–108.
5. Bell, R. M., M. M. Mocanu, and D. M. Yellon. 2011. Retrograde heart perfusion: the Langendorff technique of isolated heart perfusion. J. Mol. Cell. Cardiol. 50:940–950.
6. Bernal-Mizrachi, L., C. M. Lovly, and L. Ratner. 2006. The role of NF-{kappa}B-1 and NF-{kappa}B-2-mediated resistance to apoptosis in lymphomas. Proc. Natl Acad. Sci. USA 103:9220–9225.
7. Bikkavilli, R. K., M. E. Feigin, and C. C. Malbon. 2008. p38 mitogen-activated protein kinase regulates canonical Wnt-beta-catenin signaling by inactivation of GSK3beta. J. Cell Sci. 121:3598–3607.
8. Bogaard, H. J., R. Natarajan, S. C. Henderson, C. S. Long, D. Kraskauskas, L. Smithson, et al. 2009. Chronic pulmonary artery pressure elevation is insufficient to explain right heart failure. Circulation 120:1951–1960.
9. Bogaard, H. J., R. Natarajan, S. Mizuno, A. Abbate, P. J. Chang, V. Q. Chau, et al. 2010. Adrenergic receptor blockade reverses right heart remodeling and dysfunction in pulmonary hypertensive rats. Am. J. Respir. Crit. Care Med. 182:652–660.
10. Chandra, S. M., H. Razavi, J. Kim, R. Agrawal, R. K. Kundu, V. De Jesus Perez, et al. 2011. Disruption of the apelin-APJ system worsens hypoxia-induced pulmonary hypertension. Arterioscler. Thromb. Vasc. Biol. 31:814–820.
11. Choi, S., Z. Chen, L. H. Tang, Y. Fang, S. J. Shin, N. C. Panarelli, et al. 2016. Bcl-xL promotes metastasis independent of its anti-apoptotic activity. Nat. Commun. 7:10384.
12. Condorelli, G., C. Morisco, G. Stassi, A. Notte, F. Farina, G. Sgaramella, et al. 1999. Increased cardiomyocyte apoptosis and changes in proapoptotic and antiapoptotic genes Bax and Bcl-2 during left ventricular adaptations to chronic pressure overload in the rat. Circulation 99:3071–3078.
13. Da Silva Gonçalves Bos, D., C. Happé, I. Schalij, W. Pijacka, J. F. R. Paton, C. Guignabert, et al. 2017. Renal denervation reduces pulmonary vascular remodeling and right ventricular diastolic stiffness in experimental pulmonary hypertension. JACC Basic Transl. Sci. 2:22–35.
14. Dalzell, J. R., J. P. Rocchiccioli, R. A. Weir, C. E. Jackson, N. Padmanabhan, R. S. Gardner, et al. 2015. The emerging potential of the apelin-APJ system in heart failure. J. Card. Fail. 21:489–498.
15. Drake, J. I., H. J. Bogaard, S. Mizuno, B. Clifton, B. Xie, Y. Gao, et al. 2011. Molecular signature of a right heart failure program in chronic severe pulmonary hypertension. Am. J. Respir. Cell Mol. Biol. 45:1239–1247.
16. Dweik, R. A., S. Rounds, S. C. Erzurum, S. Archer, K. Fagan, P. M. Hassoun, et al. 2014. An official American Thoracic Society statement: pulmonary hypertension phenotypes. Am. J. Respir. Crit. Care Med. 189:345–355.
17. Erzurum, S., S. I. Rounds, T. Stevens, M. Aldred, J. Aliotta, S. L. Archer, et al. 2010. Strategic plan for lung vascular research: an NHLBI-ORDR workshop report. Am. J. Respir. Crit. Care Med. 182:1554–1562.
18. Friedberg, M. K., and A. N. Redington. 2014. Right versus left ventricular failure: differences, similarities, and interactions. Circulation 129:1033–1044.
19. Frump, A. L., K. N. Goss, A. Vayl, M. Albrecht, A. Fisher, R. Tursunova, et al. 2015. Estradiol improves right ventricular function in rats with severe angioproliferative pulmonary hypertension: effects of endogenous and exogenous sex hormones. Am. J. Physiol. Lung Cell. Mol. Physiol. 308:L873–L890.
20. Handoko, M. L., R. R. Lamberts, E. M. Redout, F. S. De Man, C. Boer, W. S. Simonides, et al. 2009. Right ventricular pacing improves right heart function in experimental pulmonary arterial hypertension: a study in the isolated heart. Am. J. Physiol. Heart Circ. Physiol. 297:H1752–H1759.
21. Hsu, S., B. A. Houston, E. Tampakakis, A. C. Bacher, P. S. Rhodes, S. C. Mathai, et al. 2016. Right ventricular functional reserve in pulmonary arterial hypertension. Circulation 133:2413–2422.
22. Humbert, M., O. Sitbon, A. Chaouat, M. Bertocchi, G. Habib, V. Gressin, et al. 2010. Survival in patients with idiopathic, familial, and anorexigen-associated pulmonary arterial hypertension in the modern management era. Circulation 122:156–163.
23. Jiang, L., S. C. Siu, M. D. Handschumacher, J. Luis Guererro, J. A. Vazquez De Prada, M. E. King, et al. 1994. Three-dimensional echocardiography. In vivo validation for right ventricular volume and function. Circulation 89:2342–2350.
24. Jiang, Y., Y. Zeng, X. Huang, Y. Qin, W. Luo, S. Xiang, et al. 2016. Nur77 attenuates endothelin-1 expression via downregulation of NF-kappaB and p38 MAPK in A549 cells and in an ARDS rat model. Am. J. Physiol. Lung Cell. Mol. Physiol. 311:L1023–l1035.
25. Kim, H. P., X. Wang, J. Zhang, G. Y. Suh, I. J. Benjamin, S. W. Ryter, et al. 2005. Heat shock protein-70 mediates the cytoprotective effect of carbon monoxide: involvement of p38 beta MAPK and heat shock factor-1. J. Immunol. 175:2622–2629.
26. Lahm, T., M. Albrecht, A. J. Fisher, M. Selej, N. G. Patel, J. A. Brown, et al. 2012. 17beta-Estradiol attenuates hypoxic pulmonary hypertension via estrogen receptor-mediated effects. Am. J. Respir. Crit. Care Med. 185:965–980.
27. Lahm, T., A. L. Frump, M. E. Albrecht, A. J. Fisher, T. G. Cook, T. J. Jones, et al. 2016. 17beta-Estradiol mediates superior adaptation of right ventricular function to acute strenuous exercise in female rats with severe pulmonary hypertension. Am. J. Physiol. Lung Cell. Mol. Physiol. 311:L375–L388.
28. Li, L., H. Zeng, and J. X. Chen. 2012. Apelin-13 increases myocardial progenitor cells and improves repair postmyocardial infarction. Am. J. Physiol. Heart Circ. Physiol. 303:H605–H618.
29. Lin, C. F., C. L. Chen, W. T. Chang, M. S. Jan, L. J. Hsu, R. H. Wu, et al. 2005. Bcl-2 rescues ceramide- and etoposide-induced mitochondrial apoptosis through blockage of caspase-2 activation. J. Biol. Chem. 280:23758–23765.
30. Liu, A., J. Philip, K. C. Vinnakota, F. Van Den Bergh, D. M. Tabima, T. Hacker, et al. 2017. Estrogen maintains mitochondrial content and function in the right ventricle of rats with pulmonary hypertension. Physiol Rep, 5:e13157.
31. Maarman, G., S. Lecour, G. Butrous, F. Thienemann, and K. Sliwa. 2013. A comprehensive review: the evolution of animal models in pulmonary hypertension research; are we there yet? Pulm. Circ. 3:739–756.
32. Misao, J., Y. Hayakawa, M. Ohno, S. Kato, T. Fujiwara, and H. Fujiwara. 1996. Expression of bcl-2 protein, an inhibitor of apoptosis, and Bax, an accelerator of apoptosis, in ventricular myocytes of human hearts with myocardial infarction. Circulation 94:1506–1512.
33. Nagendran, J., S. L. Archer, D. Soliman, V. Gurtu, R. Moudgil, A. Haromy, et al. 2007. Phosphodiesterase type 5 is highly expressed in the hypertrophied human right ventricle, and acute inhibition of phosphodiesterase type 5 improves contractility. Circulation 116:238–248.
34. Nagendran, J., G. Sutendra, I. Paterson, H. C. Champion, L. Webster, B. Chiu, et al. 2013. Endothelin axis is upregulated in human and rat right ventricular hypertrophy. Circ. Res. 112:347–354.
35. Neto-Neves, E. M., M. B. Brown, M. V. Zaretskaia, S. Rezania, A. G. Goodwill, B. P. Mccarthy, et al. 2017. Chronic embolic pulmonary hypertension caused by pulmonary embolism and vascular endothelial growth factor inhibition. Am. J. Pathol. 187:700–712.
36. Piao, L., Y. H. Fang, V. J. Cadete, C. Wietholt, D. Urboniene, P. T. Toth, et al. 2010. The inhibition of pyruvate dehydrogenase kinase improves impaired cardiac function and electrical remodeling in two models of right ventricular hypertrophy: resuscitating the hibernating right ventricle. J. Mol. Med. 88:47–60.
37. Rabinovitch, M. 2012. Molecular pathogenesis of pulmonary arterial hypertension. J. Clin. Invest. 122:4306–4313.
38. Rain, S., M. L. Handoko, P. Trip, C. T. Gan, N. Westerhof, G. J. Stienen, et al. 2013. Right ventricular diastolic impairment in patients with pulmonary arterial hypertension. Circulation 128:1–10.
39. Rane, M. J., Y. Pan, S. Singh, D. W. Powell, R. Wu, T. Cummins, et al. 2003. Heat shock protein 27 controls apoptosis by regulating Akt activation. J. Biol. Chem. 278:27828–27835.
40. Schallner, N., S. Schwemmers, C. I. Schwer, C. Froehlich, P. Stoll, M. Humar, et al. 2011. p38beta-regulated induction of the heat shock response by carbon monoxide releasing molecule CORM-2 mediates cytoprotection in lung cells in vitro. Eur. J. Pharmacol. 670:58–66.
41. Shin, J. H., J. Y. Jeong, Y. Jin, I. D. Kim, and J. K. Lee. 2011. p38beta MAPK affords cytoprotection against oxidative stress-induced astrocyte apoptosis via induction of alphaB-crystallin and its anti-apoptotic function. Neurosci. Lett. 501:132–137.
42. Slone, S. R., M. Lesort, and T. A. Yacoubian. 2011. 14-3-3theta Protects against neurotoxicity in a cellular parkinson's disease model through inhibition of the apoptotic factor Bax. PLoS ONE 6:e21720.
43. Stenmark, K. R., B. Meyrick, N. Galie, W. J. Mooi, and I. F. Mcmurtry. 2009. Animal models of pulmonary arterial hypertension: the hope for etiological discovery and pharmacological cure. Am. J. Physiol. Lung Cell. Mol. Physiol. 297:L1013–L1032.
44. Tang, G., Z. Yue, Z. Talloczy, T. Hagemann, W. Cho, A. Messing, et al. 2008. Autophagy induced by Alexander disease-mutant GFAP accumulation is regulated by p38/MAPK and mTOR signaling pathways. Hum. Mol. Genet. 17:1540–1555.
45. Taraseviciene-Stewart, L., Y. Kasahara, L. Alger, P. Hirth, G. Mc Mahon, J. Waltenberger, et al. 2001. Inhibition of the VEGF receptor 2 combined with chronic hypoxia causes cell death-dependent pulmonary endothelial cell proliferation and severe pulmonary hypertension. Faseb J. 15:427–438.
46. Temple, I. P., S. J. Logantha, M. Absi, Y. Zhang, E. Pervolaraki, J. Yanni, et al. 2016. Atrioventricular node dysfunction and ion channel transcriptome in pulmonary hypertension. Circ Arrhythm Electrophysiol, 9:e003432.
47. Tuder, R. M., S. L. Archer, P. Dorfmuller, S. C. Erzurum, C. Guignabert, E. Michelakis, et al. 2013a. Relevant issues in the pathology and pathobiology of pulmonary hypertension. J. Am. Coll. Cardiol. 62:D4–D12.
48. Tuder, R. M., E. Stacher, J. Robinson, R. Kumar, and B. B. Graham. 2013b. Pathology of pulmonary hypertension. Clin. Chest Med. 34:639–650.
49. Umar, S., J. H. Lee, E. De Lange, A. Iorga, R. Partow-Navid, A. Bapat, et al. 2012. Spontaneous ventricular fibrillation in right ventricular failure secondary to chronic pulmonary hypertension. Circ. Arrhythm Electrophysiol. 5:181–190.
50. Van Campen, J. S., K. De Boer, M. C. Van De Veerdonk, C. E. Van Der Bruggen, C. P. Allaart, P. G. Raijmakers, et al. 2016. Bisoprolol in idiopathic pulmonary arterial hypertension: an explorative study. Eur. Respir. J. 48:787–796.
51. Van De Veerdonk, M. C., T. Kind, J. T. Marcus, G. J. Mauritz, M. W. Heymans, H. J. Bogaard, et al. 2011. Progressive right ventricular dysfunction in patients with pulmonary arterial hypertension responding to therapy. J. Am. Coll. Cardiol. 58:2511–2519.
52. Voelkel, N. F., R. A. Quaife, L. A. Leinwand, R. J. Barst, M. D. Mcgoon, D. R. Meldrum, et al. 2006. Right ventricular function and failure: report of a National Heart, Lung, and Blood Institute working group on cellular and molecular mechanisms of right heart failure. Circulation 114:1883–1891.
53. Vonk Noordegraaf, A., B. E. Westerhof, and N. Westerhof. 2017. The relationship between the right ventricle and its load in pulmonary hypertension. J. Am. Coll. Cardiol. 69:236–243.
54. Vonk-Noordegraaf, A., F. Haddad, K. M. Chin, P. R. Forfia, S. M. Kawut, J. Lumens, et al. 2013. Right heart adaptation to pulmonary arterial hypertension: physiology and pathobiology. J. Am. Coll. Cardiol. 62:D22–D33.
55. Wang, W., S. M. Mckinnie, V. B. Patel, G. Haddad, Z. Wang, P. Zhabyeyev, et al. 2013. Loss of Apelin exacerbates myocardial infarction adverse remodeling and ischemia-reperfusion injury: therapeutic potential of synthetic Apelin analogues. J. Am. Heart Assoc. 2:e000249.
56. Watts, J. A., J. Zagorski, M. A. Gellar, B. G. Stevinson, and J. A. Kline. 2006. Cardiac inflammation contributes to right ventricular dysfunction following experimental pulmonary embolism in rats. J. Mol. Cell. Cardiol. 41:296–307.
57. Yang, P., C. Read, R. E. Kuc, G. Buonincontri, M. Southwood, R. Torella, et al. 2017. Elabela/toddler is an endogenous agonist of the Apelin APJ receptor in the adult cardiovascular system, and exogenous administration of the peptide compensates for the downregulation of its expression in pulmonary arterial hypertension. Circulation 135:1160–1173.
58. Zagorski, J., M. A. Gellar, M. Obraztsova, J. A. Kline, and J. A. Watts. 2007. Inhibition of CINC-1 decreases right ventricular damage caused by experimental pulmonary embolism in rats. J. Immunol. 179:7820–7826.
59. Zarubin, T., and J. Han. 2005. Activation and signaling of the p38 MAP kinase pathway. Cell Res. 15:11–18.
60. Zhang, H., Y. Qi, Y. Yuan, L. Cai, H. Xu, L. Zhang, et al. 2017. Paeoniflorin ameliorates experimental autoimmune encephalomyelitis via inhibition of dendritic cell function and Th17 cell differentiation. Sci. Rep. 7:41887.